Celaid Therapeutics logo

Celaid Therapeutics jobs and careers

Japan

About Celaid Therapeutics

Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its origins, including bone marrow, cord blood, or peripheral blood. By using the novel technology, we are developing a cell therapy product that brings HSC transplantation to the next level and helps patients with blood disorders. Our technology has many potential applications including gene/cell therapy that utilize gene editing on HSC. Our mission is to improve QOL of patients, their families, and HSC donors all over the world.

Founded in 2020 by Motoo Watanabe and Nobuyuki Arakawa.

Founded
2020
Employees
11 to 50
Total funding
$460M
Headquarters
Japan

Leadership

The top of Celaid Therapeutics's org chart, with how many people report into each leader.

NAPhoto of Nobuyuki Arakawa

Nobuyuki Arakawa

President & CEO